Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man.
about
A kinetic study of the main guaco metabolites using syrup formulation and the identification of an alternative route of coumarin metabolism in humansAnalysis and distribution of esculetin in plasma and tissues of rats after oral administration.Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats.Inter-individual Variability of Coumarin 7-hydroxylation (CYP2A6 activity) in an Iranian PopulationChanges in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.Pilot study on bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained-release dosage form.Physiologically based toxicokinetic modelling as a tool to support risk assessment: three case studies.In vitro modulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity.Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to CoumarinNew Metabolites of Coumarin Detected in Human Urine Using Ultra Performance Liquid Chromatography/Quadrupole-Time-of-Flight Tandem Mass Spectrometry.Phagocytosis and killing of Salmonella by 7-hydroxycoumarin activated macrophages.Liver slices in dynamic organ culture. II. An in vitro cellular technique for the study of integrated drug metabolism using human tissue.Evaluation of mesoporous silicate nanoparticles for the sustained release of the anticancer drugs: 5-fluorouracil and 7-hydroxycoumarin
P2860
Q28543941-2164B601-9597-4244-88DB-4E7A07B41635Q34872174-4B934D5F-6F0C-4416-8A40-5129FD2A775FQ35115683-5AD8B339-32DD-4051-977F-22643ACF5B8FQ37292058-29CECC2F-C549-43C8-8146-936F1C787759Q37317619-9F8D5CBA-2D35-4A46-AA2E-ED2409ADEAB6Q41636847-016126E0-E698-44E2-A94D-1A87CB68EC34Q41850809-C0AAA148-9FFC-4194-8CFF-F335B520DC3EQ43093974-BB1F78BB-5D84-4F70-AE6E-4F922CF91011Q44677954-54A36436-331A-4EF5-AA95-476D2AA9F0D6Q47143483-7E4DFE31-0635-4F47-89AF-7F09350F264EQ49815350-6AB509D5-7821-4EE8-92E5-D9EEA8248F47Q50035116-EE1B455F-AD31-4546-950D-7FC17489F76CQ52446746-22AEDFFE-1F13-4E7A-BF39-7E198BEE56D6Q57350839-AA577C87-22D4-45AC-AE18-D05FC9E30D07
P2860
Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh-hant
name
Pharmacokinetics of coumarin a ...... nistration of coumarin in man.
@en
Pharmacokinetics of coumarin a ...... nistration of coumarin in man.
@nl
type
label
Pharmacokinetics of coumarin a ...... nistration of coumarin in man.
@en
Pharmacokinetics of coumarin a ...... nistration of coumarin in man.
@nl
prefLabel
Pharmacokinetics of coumarin a ...... nistration of coumarin in man.
@en
Pharmacokinetics of coumarin a ...... nistration of coumarin in man.
@nl
P2093
P356
P1476
Pharmacokinetics of coumarin a ...... nistration of coumarin in man.
@en
P2093
K A Hoffmann
K W Grummich
W A Ritschel
P2888
P304
P356
10.1007/BF00561066
P577
1977-12-01T00:00:00Z